The mRNA expression of ECE-1 showed a trend of an increase under ISDN therapy and a complete normalization by cotherapy with macitentan ( Figure 9(b) ).
← all excerpts
The Endothelin Receptor Antagonist Macitentan Improves Isosorbide-5-Mononitrate (ISMN) and Isosorbide Dinitrate (ISDN) Induced Endothelial Dysfunction, Oxidative Stress, and Vascular Inflammation.
1
—
—